Page last updated: 2024-09-03

nitroaspirin and Liver Steatosis

nitroaspirin has been researched along with Liver Steatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdelrahman, AM; Farghaly, E; Gomaa, W; Ibrahim, M; Kelleni, M	1

Other Studies

1 other study(ies) available for nitroaspirin and Liver Steatosis

Article	Year
Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease. European journal of pharmacology, 2011, Jun-01, Volume: 659, Issue:2-3 Topics: Alanine Transaminase; Animals; Aspirin; Cyclooxygenase 2; Fatty Liver; Gene Expression Regulation, Enzymologic; Liver; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Triglycerides	2011

Article

Year

Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease.

European journal of pharmacology, 2011, Jun-01, Volume: 659, Issue:2-3

Topics: Alanine Transaminase; Animals; Aspirin; Cyclooxygenase 2; Fatty Liver; Gene Expression Regulation, Enzymologic; Liver; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Triglycerides

2011